Reply to 'Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers'.
about
Reply to 'Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers'.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Reply to 'Biosimilars: a posit ...... ence to oncology prescribers'.
@en
Reply to 'Biosimilars: a posit ...... ence to oncology prescribers'.
@nl
type
label
Reply to 'Biosimilars: a posit ...... ence to oncology prescribers'.
@en
Reply to 'Biosimilars: a posit ...... ence to oncology prescribers'.
@nl
prefLabel
Reply to 'Biosimilars: a posit ...... ence to oncology prescribers'.
@en
Reply to 'Biosimilars: a posit ...... ence to oncology prescribers'.
@nl
P2860
P1433
P1476
Reply to 'Biosimilars: a posit ...... rence to oncology prescribers'
@en
P2093
Thomas Schreitmüller
P2860
P304
P356
10.1136/ESMOOPEN-2017-000281
P577
2017-10-23T00:00:00Z